摘要
背景:肠靶向药物是口服给药的化合物,其在肠道局部发挥其治疗作用,从而避免了与全身暴露有关的副作用。 目标:因此,学术研究和药物研究都集中在这类药物上,但其设计和评估所需的系统方法尚不清楚。因此,对这种药物的仔细总结对药物设计至关重要。 方法:综述2013 - 2016年通过文献,专利和相关网站开发口服小分子药物肠靶向药物的成果。 结果:本综述根据各种设计策略总结了6类肠道靶向药物,仔细分析了各类最近的实例。 结论:我们的分析表明,肠道靶向分布可以扩大药物的治疗窗口,同时保留其功效。因此,我们描述适用于肠靶向药物的合理设计的简单方法。
关键词: 肠靶向药物,设计策略,亲脂性,水溶性,分子量,软药物,前体药物,外排转运蛋白
Current Medicinal Chemistry
Title:Orally Administrated Small Molecule Drugs with Intestine Targeted Profile: Recent Development and Prospects
Volume: 24 Issue: 35
关键词: 肠靶向药物,设计策略,亲脂性,水溶性,分子量,软药物,前体药物,外排转运蛋白
摘要: Background: Intestine targeted drugs are orally administered compounds exerting their therapeutic effects locally in the intestinal tract, thus avoiding side effects related to systemic exposure.
Objective: Both academic and pharmaceutical research has, therefore, focused on such agents, but the systematic methodology needed for their design and evaluation has been unclear. Thus, careful summary of this kind of drugs is vital for drug design.
Method: This review summarizes achievements from 2013 to 2016, through literatures, patents and related websites, in developing orally administrated small molecule drugs with intestine targeted profile.
Results: This review summarized six categories of intestine targeted drugs, based on various design strategies, with careful analysis of recent examples from each category.
Conclusion: Our analysis indicated that the intestine targeted profile could expand the therapeutic window of drugs while retaining their efficacy. Thus, we describe simple approaches suitable for rational design of intestine targeted drugs.
Export Options
About this article
Cite this article as:
Orally Administrated Small Molecule Drugs with Intestine Targeted Profile: Recent Development and Prospects, Current Medicinal Chemistry 2017; 24 (35) . https://dx.doi.org/10.2174/0929867324666170810154414
DOI https://dx.doi.org/10.2174/0929867324666170810154414 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Notch as a Therapeutic Approach for Human Malignancies
Current Pharmaceutical Design Clinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver Diseases
Current Clinical Pharmacology Notch Signaling in Normal and Disease States: Possible Therapies Related to Glycosylation
Current Molecular Medicine What Does a Pediatrician Need to Know About Chronic Diarrhea?
Current Pediatric Reviews Genetics of Congenital Heart Disease
Current Cardiology Reviews PET Tracers for Serotonin Receptors and Their Applications
Central Nervous System Agents in Medicinal Chemistry Current Options for Treatment of End-Stage Liver Disease in Children
Current Pediatric Reviews Neurocognitive Monitoring and Care During Pediatric Cardiopulmonary Bypass — Current and Future Directions
Current Cardiology Reviews NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment
Current Medicinal Chemistry Notch Signaling in Cardiovascular Disease and Calcification
Current Cardiology Reviews Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections
Current Pharmaceutical Design New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular Targets
Current Drug Targets Recent Developments in Group I Metabotropic Glutamate Receptor Allosteric Modulators for the Treatment of Psychiatric and Neurological Disorders (2014-May 2015)
Current Topics in Medicinal Chemistry Renal Development: A Complex Process Dependent on Inductive Interaction
Current Pediatric Reviews Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs
Current Drug Therapy Notch Signalling Pathways and Their Importance in the Treatment of Cancers
Current Drug Targets Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
Current Neuropharmacology Congenital Scoliosis (Mini-review)
Current Pediatric Reviews Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling
Current Stem Cell Research & Therapy Pharmacological Therapy of Parkinson’s Disease: Current Options and New Avenues
Recent Patents on CNS Drug Discovery (Discontinued)